RSHL1 Inhibitors
RSHL1 inhibitors are a class of compounds that can indirectly decrease the functional activity of RSHL1 by targeting various signaling pathways that RSHL1 may be involved in. Staurosporine, as a broad-spectrum kinase inhibitor, can interfere with the phosphorylation states of proteins that would activate RSHL1, thereby reducing its activity. LY294002 and Wortmannin are both inhibitors of PI3K, a key component of the PI3K/AKT pathway. This pathway is integral to a range of cellular functions, including those related to ciliary processes, which RSHL1 could be a part of. By inhibiting PI3K, these compounds prevent the activation of AKT and subsequent downstream signaling events, likely resulting in decreased RSHL1 activity.
Further dissecting the signaling pathways that govern RSHL1 activity, PD98059 and U0126, both MEK inhibitors, prevent the activation of the MAPK pathway. If RSHL1 is regulated by MAPK signaling, these inhibitors wouldlead to reduced RSHL1 function. SB203580, a p38 MAPK inhibitor, and SP600125, a JNK inhibitor, also target the MAPK pathway but at different nodes. These specific inhibitions suggest that if RSHL1 is subject to regulation by stress or JNK-mediated signaling, its activity would be impeded by these compounds. Rapamycin inhibits mTOR, a central regulator of cell growth and metabolism, which could be crucial if RSHL1 plays a role in these processes or in the regulation of cilia, as mTOR signaling is known to influence cilia length and function. Bafilomycin A1's inhibition of V-ATPases could alter intracellular conditions necessary for RSHL1's proper functioning, especially if RSHL1 is sensitive to pH or ionic changes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. By inhibiting various kinases that phosphorylate RSHL1, staurosporine can indirectly prevent RSHL1 activation, as phosphorylation is often a key regulatory event for protein function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which impedes the PI3K/AKT pathway. RSHL1, if involved in ciliary function, may rely on AKT-mediated signaling for its activation or stabilization. Inhibition of this pathway can lead to functional suppression of RSHL1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, similar to LY294002. It blocks the PI3K/AKT pathway, potentially leading to decreased activity of proteins associated with this pathway, including RSHL1 if its function is related to cilia maintenance, which is often regulated by PI3K/AKT signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. If RSHL1 is regulated by MAPK signaling, PD98059 would lead to decreased activation of RSHL1 through inhibition of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. It prevents the activation of p38 MAPK, which could indirectly inhibit RSHL1 activity if RSHL1 is modulated by stress-responsive MAPK pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK family. Inhibition of JNK can lead to decreased activity of downstream proteins regulated by JNK signaling, potentially including RSHL1 if it is JNK-dependent. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, rapamycin can inhibit downstream signaling that may be required for the functional activity of RSHL1, especially if RSHL1 is linked to cellular growth or cilia length regulation processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 specifically inhibits V-ATPases, which could disrupt intracellular pH and ion homeostasis. If RSHL1's function depends on these parameters, its activity could be indirectly inhibited. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin. By inhibiting calcineurin, Cyclosporin A may affect the dephosphorylation state of proteins potentially interacting with RSHL1, leading to its decreased activation. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. If RSHL1 is activated by phosphorylation through Src kinases, PP2 would decrease its functional activity by inhibiting its phosphorylation. | ||||||